← Open Payments lookup

VICTOR LABRADO: Open Payments

NPI 1629629803 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,237 in 58 payments from 11 companies in 2025. Trend: 2023 $1,133 · 2024 $926 · 2025 $2,237

Food & beverage: $2,237
CompanyPaymentsAmount
Axsome Therapeutics, Inc.14$594
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$489
ABBVIE INC.13$313
Vanda Pharmaceuticals Inc.5$230
Supernus Pharmaceuticals, Inc.5$180
Otsuka America Pharmaceutical, Inc.3$148
E.R. Squibb & Sons, L.L.C.1$126
Teva Pharmaceuticals USA, Inc.3$82
Novo Nordisk Inc1$29
Janssen Pharmaceuticals, Inc1$28

Products named: Auvelity, CAPLYTA, VRAYLAR, FANAPT, Qelbree, REXULTI, COBENFY, UZEDY.

Industry payments across TX — which companies pay providers there.